Abstract
Outcome after surgical treatment has been based predominantly on objective criteria. A more global assessment is necessary which also includes patient-reported health-related quality of life. The literature concerning investigations on quality of life measurements in surgery and follow-up in colorectal cancer is reviewed. Only a few studies are published; the results are conflicting and the methodology questionable. Therefore, it is concluded that there is a strong need for further research in this field.
Keywords: Colorectal cancer surgery, quality of life assessments, follow-up
Current Cancer Therapy Reviews
Title: Quality of Life Assessments in Colorectal Cancer Surgery. A Review
Volume: 4 Issue: 4
Author(s): Per Jess
Affiliation:
Keywords: Colorectal cancer surgery, quality of life assessments, follow-up
Abstract: Outcome after surgical treatment has been based predominantly on objective criteria. A more global assessment is necessary which also includes patient-reported health-related quality of life. The literature concerning investigations on quality of life measurements in surgery and follow-up in colorectal cancer is reviewed. Only a few studies are published; the results are conflicting and the methodology questionable. Therefore, it is concluded that there is a strong need for further research in this field.
Export Options
About this article
Cite this article as:
Jess Per, Quality of Life Assessments in Colorectal Cancer Surgery. A Review, Current Cancer Therapy Reviews 2008; 4 (4) . https://dx.doi.org/10.2174/157339408786413335
DOI https://dx.doi.org/10.2174/157339408786413335 |
Print ISSN 1573-3947 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6301 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Regulation of the Endoplasmic Reticulum Ca2+-Store in Cancer
Anti-Cancer Agents in Medicinal Chemistry Dual-Specificity MAP Kinase Phosphatases as Targets of Cancer Treatment
Anti-Cancer Agents in Medicinal Chemistry Sirtuin Inhibitors: An Overview from Medicinal Chemistry Perspective
Anti-Cancer Agents in Medicinal Chemistry Kinase Inhibitors Targeting Anti-angiogenesis as Anti-cancer Therapies
Current Angiogenesis (Discontinued) Prostate Cancer Gene Expression Marker 1 (PCGEM1): A Patented Prostate- Specific Non-Coding Gene and Regulator of Prostate Cancer Progression
Recent Patents on DNA & Gene Sequences Pharmacogenetics of Irinotecan Disposition and Toxicity: A Review
Current Clinical Pharmacology Simultaneous Modeling of Antimycobacterial Activities and ADMET Profiles: A Chemoinformatic Approach to Medicinal Chemistry
Current Topics in Medicinal Chemistry MicroRNA-21 as a Novel Therapeutic Target
Current Cancer Therapy Reviews Cognitive Functions under Anti-HER2 Targeted Therapy in Cancer Patients: A Scoping Review
Endocrine, Metabolic & Immune Disorders - Drug Targets Solid Lipid Nanoparticles: A Promising Nanomaterial in Drug Delivery
Current Pharmaceutical Design Connecting A Tumor to the Environment
Current Pharmaceutical Design Epigenetic Regulation and Promising Therapies in Colorectal Cancer
Current Molecular Pharmacology In Silico Design of Phenylbenzamide Derivatives Coupled to Pyrimidines as Novel hnRNP K Ligands Against Cancer
Current Bioactive Compounds Evaluating Intestinal Permeability by Measuring Plasma Endotoxin and Diamine Oxidase in Children with Acute Lymphoblastic Leukemia Treated with High-dose Methotrexate
Anti-Cancer Agents in Medicinal Chemistry Comparative DFT Study of 5-Fluorouracil Adsorption on Silica and Graphene for Bio-Medical Applications
Micro and Nanosystems Advances of AKT Pathway in Human Oncogenesis and as a Target for Anti-Cancer Drug Discovery
Current Cancer Drug Targets Microparticles in Health and Disease: Small Mediators, Large Role?
Current Vascular Pharmacology MicroRNA Polymorphisms, MicroRNA Pharmacogenomics and Cancer Susceptibility
Current Pharmacogenomics and Personalized Medicine Reversal of ABC Drug Transporter-Mediated Multidrug Resistance in Cancer Cells: Evaluation of Current Strategies
Current Molecular Pharmacology Use of Anticancer Platinum Compounds in Combination Therapies and Challenges in Drug Delivery
Current Medicinal Chemistry